Mutations in the gene in Stargardt disease (STGD1) cause enhanced accumulation of cytotoxic lipofuscin, manifesting in RPE atrophy and photoreceptor dysfunction. One component of lipofuscin is the all--retinal derivative, pyridinium bisretinoid A2E. Since ocular A2E biosynthesis relies on all--retinal, which is obtained from circulating all--retinol bound to retinol binding protein 4 (RBP4-ROL), we hypothesized that modulating vitamin A receptors, such as RBPR2, which regulate serum RBP4-ROL homeostasis, should in principle attenuate A2E production. In silico analysis revealed multiple retinoic acid response element (RARE) binding sites on the murine gene promoter, which was confirmed in vitro by EMSA and ChIP assays. In vitro luciferase assays showed that promoter activity was induced by exogenous β-carotene (BC) metabolites. Dietary BC supplementation of mice, a mouse model for STGD1, increased hepatic all--retinoic acid and 9--retinoic acid production, which induced mRNA expression. This mechanism decreased serum RBP4 protein levels, fundus lipofuscin autofluorescence, and ocular A2E accumulation, altogether improving photoreceptor and RPE function. Conversely, such a rescue was not observed in either mice fed a diet devoid of BC or in double knockout ; mice. Thus, there was a significant inverse correlation between dietary BC supplementation and gene presence in mice, to that of lipofuscin accumulation in mice on diets devoid of BC or in ; mice. Our results provide impetus to include dietary obtained BC for STGD1 patients with gene mutations and identify a novel role for the vitamin A receptor RBPR2 in this process.